Oligometastatic Disease (OMD) Comprehensive Guide: Limited Metastasis and Recovery

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer: Oligometastatic Disease at a Glance

Oligometastatic disease (OMD) is cancer that has spread to a few places in the body, usually one to five tumors, often growing more slowly and less likely to spread than typical metastatic cancer. [1] Common sites include bones, brain, liver and lungs. [1] Treatment with surgery and stereotactic body radiation therapy, often with systemic therapy, can sometimes achieve cure or long-term remission. [1]

Feature	Details
Medical name	Oligometastatic disease (OMD).
Core definition	Cancer that has spread to a few places in the body, usually one to five tumors. [1]
Growth pattern	Often grows more slowly and is less likely to spread than typical metastatic cancer. [1]
Common sites	Bones, brain, liver, lungs, adrenal glands, and lymph nodes. [1]
Primary treatments	Surgery and stereotactic body radiation therapy (SBRT), often combined with systemic therapy. [1]
Goal of care	Cure or long-term remission in some cases. [1]
Diagnosis timing	Synchronous (found with the primary tumor or within six months) or metachronous (found later). [1]

What the research says

• Adding SABR to standard care was linked to longer survival in a randomized trial. In the SABR-COMET phase II trial (99 people with 1–5 metastases), 5-year overall survival was 42.3% with stereotactic ablative radiotherapy (SABR) plus standard care versus 17.7% with standard palliative care alone, with no new grade 2–5 adverse events and no difference in quality of life. It was a phase II screening trial, so larger trials are needed. (Palma et al., J Clin Oncol, 2020) [2]

• SBRT alone may let some people delay systemic therapy. A systematic review of 29 studies (2,074 people with up to five metastases) pooled data from 13 studies (984 people) and found that 69.7% (95% CI 57.4%–80.9%) were still free of systemic therapy at 1 or 2 years after SBRT alone, highest in kidney cancer (87.0%) and prostate cancer (78.1%). Grade 3 or higher adverse events were absent in 15 of 19 studies (79%) with available data. The analysis did not compare SBRT with systemic therapy directly. (Willmann et al., JAMA Netw Open, 2025) [3]

What Is Oligometastatic Disease?

Oligometastatic disease (OMD) represents a middle ground between localized cancer and widespread metastatic disease. In this subtype of stage IV cancer, the primary tumor has shed cells that have formed new tumors in other parts of the body, but these new growths are few in number, usually between one and five. [1] The term “oligo” comes from the Greek word for “few,” reflecting the limited nature of the spread.

Healthcare providers distinguish OMD from typical metastatic cancer by its behavior and treatment potential. Typical metastatic cancer is usually treated with systemic therapies such as chemotherapy to address widespread disease. [1] With OMD, providers can often combine systemic therapy with localized treatments that target the individual tumors, which may improve the long-term outlook. [1]

How is oligometastatic disease (OMD) classified?

Healthcare providers use specific terms to describe the different ways OMD can present and respond to treatment. Understanding them helps in tailoring the care plan.

• Oligometastatic: the standard definition, where tests detect up to five tumors. Providers may call this limited metastasis. [1]

• Oligoprogressive [1]: the primary tumor stops growing after treatment, but tumors in other areas continue to grow.

• Oligoremnant [1]: treatment removes most, but not all, of the tumors that spread from the primary tumor.

The timing of diagnosis is also described. Synchronous OMD is found at the same time as the primary tumor or within six months of diagnosis, while metachronous OMD is found later. [1]

What are the common types and spread patterns of oligometastatic disease?

OMD can occur with many types of cancer, and the pattern of spread often follows predictable paths depending on the primary cancer.

Primary cancer	Common metastatic sites
Breast cancer	Bones, brain, liver, or lungs. [1]
Colorectal cancer	Liver and lungs. [1]
Kidney cancer	Brain, lungs, and lymph nodes. [1]
Non-small cell lung cancer (NSCLC)	Adrenal glands, bones, and brain. [1]
Prostate cancer	Bones or lymph nodes. [1]
Sarcoma	Lungs or bones. [1]

What are the symptoms of oligometastatic disease, and how is it diagnosed?

The symptoms of OMD depend on where the cancer has spread. For example, breast cancer that has spread to the bones may cause bone or joint pain, while spread to the lungs may cause chest pain or a cough that does not go away. [1] Not everyone has symptoms, and OMD can be found on imaging done for staging or follow-up.

Diagnosis relies heavily on imaging. Doctors often use CT scans, PET/CT scans, MRI, or bone scans to find the location and number of tumors. [1] A biopsy may also be done to get tumor samples for analysis. [1]

Which targeted treatment strategies are used for oligometastatic disease?

The hallmark of OMD management is the use of localized treatments that may remove or destroy tumors in different areas of the body. [1]

• Surgery: surgeons may remove individual metastatic tumors. [1]

• Stereotactic body radiation therapy (SBRT): a highly focused form of radiation that delivers a large dose to a small area, destroying the tumor while sparing surrounding healthy tissue.

• Systemic therapies: surgery and SBRT may be combined with chemotherapy, targeted therapy, or immunotherapy, which may be used to treat the primary tumor. [1]

There is no set recovery time. You may recover from SBRT within a few days, while recovery from surgery may take weeks. [1] Contact your cancer care team about surgery side effects such as uncontrolled bleeding, signs of infection, or pain that does not ease with medication, and report any new or different symptoms, since these may mean OMD has come back or developed in a new area. [1]

What is the bottom line on oligometastatic disease?

Oligometastatic disease changes how some stage IV cancers are understood and treated. By identifying people with limited spread, care teams can use localized treatments such as surgery and SBRT, alongside systemic therapy, with the aim of cure or long-term remission in some cases. An OMD diagnosis still requires ongoing treatment and follow-up, but it can offer a more hopeful path and a better quality of life.

Looking for more information? For more on navigating a cancer diagnosis and exploring advanced treatment options, visit Rinnit.com.

Frequently Asked Questions

Is oligometastatic disease the same as stage IV cancer?

Oligometastatic disease is a subtype of stage IV (metastatic) cancer. [1] The difference is that OMD involves only a few tumors, usually one to five, rather than widespread disease. [1]

Can oligometastatic disease be cured?

In some cases. Targeted treatments such as surgery and radiation can remove or destroy the tumors, and this may cure OMD or lead to long-term remission. [1] You will still need treatment for the primary tumor. [1]

What does “oligo” mean in medical terms?

The prefix “oligo” comes from the Greek word for “few,” referring to the small number of metastatic tumors.

How is OMD different from typical metastatic cancer?

OMD is less widespread, often grows more slowly, is less likely to spread, and can be treated with localized therapies such as surgery and focused radiation, often alongside systemic therapy. [1]

What is SBRT?

SBRT stands for stereotactic body radiation therapy, a highly focused form of radiation that delivers a large dose to a small area to destroy a tumor while sparing nearby healthy tissue.

What is synchronous oligometastatic disease?

Synchronous oligometastatic disease is when the metastatic tumors are found at the same time as the primary tumor or within six months of diagnosis. [1] When later tests find the tumors, it is called metachronous OMD. [1]

Can prostate cancer be oligometastatic?

Yes. Prostate cancer can present as OMD, most often with spread to the bones or lymph nodes. [1]

How many tumors are usually found in OMD?

OMD is generally defined as one to five tumors in a few areas of the body [1], although definitions can vary.

Does OMD always cause symptoms?

Not always. Symptoms depend on where the cancer has spread [1], and some people have none. OMD may be found on imaging tests done for staging or follow-up.

Is chemotherapy used for OMD?

Sometimes. Chemotherapy, targeted therapy, or immunotherapy may be combined with surgery or SBRT, including to treat the primary tumor. [1]

What is oligoprogressive disease?

Oligoprogressive disease describes a situation where the primary tumor stops growing after treatment, but tumors in other areas continue to grow. [1]

What is oligoremnant disease?

Oligoremnant disease means treatment removes most, but not all, of the tumors that spread from the primary tumor. [1]

How long is the recovery from SBRT?

There is no set recovery time, but many people recover from SBRT within a few days. [1] Surgery recovery can take several weeks. [1] Your cancer care team will explain what to expect.

What imaging tests are used to find OMD?

Doctors often use CT scans, PET/CT scans, MRI, and bone scans. [1] A biopsy may also be done to analyze tumor samples. [1]

Why do some cancers stay oligometastatic?

Experts believe genetic changes (mutations) may explain why OMD differs from typical metastatic cancer and does not cause widespread disease. [1]

Related Reading

Cancer Staging and Grading: What They Are, Why They Matter, Tests and Results explains how doctors stage and grade cancer and why the results guide treatment.

References

1. Cleveland Clinic. Oligometastatic Disease (OMD). Cleveland Clinic. Updated April 15, 2026. https://my.clevelandclinic.org/health/diseases/oligometastatic-disease

2. Palma DA, et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol. 2020;38(25):2830-2838. PMID 32484754. https://doi.org/10.1200/JCO.20.00818

3. Willmann J, et al. Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2025;8(12):e2549685. PMID 41632169. https://doi.org/10.1001/jamanetworkopen.2025.49685

Medical disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.